Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration

被引:86
作者
Evans, Jennifer R. [1 ]
Lawrenson, John G. [2 ]
机构
[1] London Sch Hyg & Trop Med, Cochrane Eyes & Vis Grp, ICEH, London WC1E 7HT, England
[2] City Univ London, Div Optometry & Visual Sci, London EC1V 0HB, England
来源
COCHRANE DATABASE OF SYSTEMATIC REVIEWS | 2012年 / 11期
关键词
Dietary Supplements; Antioxidants [therapeutic use; Macular Degeneration [prevention & control; Minerals [therapeutic use; Randomized Controlled Trials as Topic; Vitamins [therapeutic use; Aged; Humans; PIGMENT OPTICAL-DENSITY; RANDOMIZED CONTROLLED-TRIALS; LUTEIN SUPPLEMENTATION; EYE DISEASE; DIETARY SUPPLEMENTATION; SERUM CONCENTRATIONS; ORAL ZINC; ZEAXANTHIN; CAROTENOIDS; MACULOPATHY;
D O I
10.1002/14651858.CD000254.pub3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background It has been proposed that antioxidants may prevent cellular damage in the retina by reacting with free radicals that are produced in the process of light absorption. Higher dietary levels of antioxidant vitamins and minerals may reduce the risk of progression of age-related macular degeneration (AMD). Objectives The objective of this review was to assess the effects of antioxidant vitamin or mineral supplementation on the progression of AMD in people with AMD. Search methods We searched CENTRAL (which contains the Cochrane Eyes and Vision Group Trials Register) (The Cochrane Library 2012, Issue 8), Ovid MEDLINE, Ovid MEDLINE In-Process and Other Non-Indexed Citations, Ovid MEDLINE Daily, Ovid OLDMEDLINE (January 1946 to August 2012), EMBASE (January 1980 to August 2012), Allied and Complementary Medicine Database (AMED) (January 1985 to August 2012), OpenGrey (System for Information on Grey Literature in Europe) (www.opengrey.eu/), the metaRegister of Controlled Trials (mRCT) (www.controlled-trials.com), ClinicalTrials.gov (www.clinicaltrials.gov) and the WHO International Clinical Trials Registry Platform (ICTRP) (www.who.int/ictrp/search/en). We did not use any date or language restrictions in the electronic searches for trials. We last searched the electronic databases on 20 August 2012. We searched the reference lists of identified reports and the Science Citation Index. We contacted investigators and experts in the field for details of unpublished studies. We also searched for systematic reviews of harms of vitamin supplements. Selection criteria We included randomised trials comparing antioxidant vitamin or mineral supplementation (alone or in combination) to placebo or no intervention in people with AMD. Data collection and analysis Two authors assessed risk of bias and extracted data from the included trials. Where appropriate, we pooled data using a random-effects model unless three or fewer trials were available in which case we used a fixed-effect model. Main results Thirteen trials (6150 participants) were included in this review. Over half the participants (3640) were randomised in one trial (AREDS in the USA), which found a beneficial effect of antioxidant (beta-carotene, vitamin C and vitamin E) and zinc supplementation on progression to advanced AMD (adjusted odds ratio (OR) 0.68, 95% confidence interval (CI) 0.53 to 0.87) over an average of 6.3 years. People taking supplements were less likely to lose 15 or more letters of visual acuity (adjusted OR 0.77, 95% CI 0.62 to 0.96). The other trials, in general, had shorter follow-up (less than two years). No evidence for an effect of supplementation was seen in these smaller trials of shorter duration. Overall we considered the strength of the evidence to be moderate. We did not consider included trials, in general, to be at risk of bias, although we found it difficult to assess reporting biases. The main reason for downgrading the strength of the evidence was because, for several analyses, only one trial was included and therefore consistency of the findings could not be assessed. The included trials reported the following adverse effects: hospitalisation for genito-urinary problems was more common in people taking zinc and yellowing of skin was more common in people taking antioxidants. Systematic searching of the literature identified other potential harms of vitamin supplementation, in particular an increased risk of lung cancer in smokers associated with beta-carotene supplements, but we were unable to identify a good systematic review of the evidence for harms of nutritional supplementation. Authors' conclusions People with AMD may experience delay in progression of the disease with antioxidant vitamin and mineral supplementation. This finding is drawn from one large trial conducted in a relatively well-nourished American population. The generalisability of these findings to other populations is not known. Although generally regarded as safe, vitamin supplements may have harmful effects. A systematic review of the evidence on harms of vitamin supplements is needed.
引用
收藏
页数:84
相关论文
共 86 条
[1]   Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries [J].
Abba, Katharine ;
Deeks, Jonathan J. ;
Olliaro, Piero ;
Naing, Cho-Min ;
Jackson, Sally M. ;
Takwoingi, Yemisi ;
Donegan, Sarah ;
Garner, Paul .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (07)
[2]  
Age-Related Eye Dis Study Res Grp, 2001, AM J OPHTHALMOL, V132, P668
[3]  
Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group, 1994, N Engl J Med, V330, P1029, DOI 10.1056/NEJM199404143301501
[4]  
[Anonymous], 2011, COCHRANE HDB SYSTEMA
[5]   Lutein supplementation in retinitis pigmentosa: PC-based vision assessment in a randomized double-masked placebo-controlled clinical trial [NCT00029289] [J].
Bahrami H. ;
Melia M. ;
Dagnelie G. .
BMC Ophthalmology, 6 (1)
[6]   Effect of niacin on retinal vascular diameter in patients with age-related macular degeneration [J].
Barakat, M. R. ;
Metelitsina, T. I. ;
DuPont, J. C. ;
Grunwald, J. E. .
CURRENT EYE RESEARCH, 2006, 31 (7-8) :629-634
[7]   Effect of lutein and antioxidant dietary supplementation on contrast sensitivity in age-related macular disease: a randomized controlled trial [J].
Bartlett, H. E. ;
Eperjesi, F. .
EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2007, 61 (09) :1121-1127
[8]   A randomised controlled trial investigating the effect of nutritional supplementation on visual function in normal, and age-related macular disease affected eyes: design and methodology [ISRCTN78467674] [J].
Bartlett, Hannah ;
Eperjesi, Frank .
NUTRITION JOURNAL, 2003, 2 (1)
[9]   Enhanced bioavailability of zeaxanthin in a milk-based formulation of wolfberry (Gou Qi!Zi; Fructus barbarum L.) [J].
Benzie, Iris F. F. ;
Chung, Wai Y. ;
Wang, Junkuan ;
Richelle, Myriam ;
Bucheli, Peter .
BRITISH JOURNAL OF NUTRITION, 2006, 96 (01) :154-160
[10]   AN INTERNATIONAL CLASSIFICATION AND GRADING SYSTEM FOR AGE-RELATED MACULOPATHY AND AGE-RELATED MACULAR DEGENERATION [J].
BIRD, AEC ;
BRESSLER, NM ;
BRESSLER, SB ;
CHISHOLM, IH ;
COSCAS, G ;
DAVIS, MD ;
DEJONG, PTVM ;
KLAVER, CCW ;
KLEIN, BEK ;
KLEIN, R ;
MITCHELL, P ;
SARKS, JP ;
SARKS, SH ;
SOURBANE, G ;
TAYLOR, HR ;
VINGERLING, JR .
SURVEY OF OPHTHALMOLOGY, 1995, 39 (05) :367-374